Favorable pharmacokinetics, pharmacodynamics and safety demonstrated for FFR-rFVIIa in humans July 30, 2001
New anticoagulants particularly suited for thrombosis and heparin-associated thrombocytopenia July 27, 2001
Texas Biotechnology receives approvable letter from FDA for expanded argatroban indication July 23, 2001
RSS